Covington & Burling advised Selecta Biosciences, Inc. on the transaction, and Foley Hoag advised Cartesian Therapeutics. Selecta Biosciences (Nasdaq:SELB) (“Selecta”) announced its merger with Cartesian Therapeutics and concurrent...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised Alexion on the transaction while Arnold & Porter represented Pfizer. AstraZeneca Rare Disease announced its entry into a definitive purchase and license agreement...
You must be a Standard 1 Year member to access this content.
Covington and NautaDutilh advised NewAmsterdam Pharma on the deal, while Latham & Watkins advised Lincoln International. Houthoff assisted Frazier Lifesciences Acquisition Corp. NewAmsterdam Pharma Holding B.V.,...
You must be a Standard 1 Year member to access this content.
White & Case advised AMCI, Covington & Burling advised LanzaTech, Ropes & Gray advised the placement agents on the deal. AMCI Acquisition Corp. II, a publicly...
You must be a Standard 1 Year member to access this content.
Covington represented UCB, while Latham & Watkins represented Zogenix on the deal. Fried Frank acted as counsel to BofA Securities and SVB Leerink as financial advisors to...
You must be a Standard 1 Year member to access this content.
Davis Polk advised FirstGroup plc on the deal while Covington & Burling LLP represented FlixMobility. FirstGroup plc finalized the sale of Greyhound Lines, Inc. to an...
You must be a Standard 1 Year member to access this content.
Morrison & Foerster and Mijares, Angoitia, Cortés y Fuentes advised SoftBank Latin America Fund on the deal. Covington & Burling and Graham Abogados advised Corporativo GBM,...
You must be a Standard 1 Year member to access this content.
